Results 1 - 10 of 11 : 1 2 Next
Pfizer is a good company, but a bad stock for 2008.
The pharma gives up its quest for bidders.
Neurochem chooses a risky path for its lead drug candidate.
These low-rated picks prove that a stock doesn't have to be loved to outperform.
World's Scariest Stock: Dendreon
Dendreon's scary future should make it an "underperform" in CAPS.
A Surprising Decision for Telik
It still doesn't look like its lead drug is helping anyone get better.
Following the Fallen Biotech Class of 2006
Ever wondered what happened to last year's biotech disaster stories?
An unsurprising response from the FDA.
Who's fallen hardest? Who can bounce highest?
Here Come the Dendreon Lawsuits
Dendreon gets sued.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK